Article info
PDFClinical and epidemiological research
Extended report
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
- Correspondence to Dr Rohit Aggarwal, Department of Medicine, Division of Rheumatology, University of Pittsburgh School of Medicine, Falk Medical Building, Suite 2B, 3601 Fifth Avenue, Pittsburgh, PA 15213, USA;aggarwalr{at}upmc.edu
- RA and EC contributed equally to the manuscript and are co-first authors.
Citation
Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients
Publication history
- Received May 6, 2012
- Revised December 9, 2012
- Accepted December 29, 2012
- First published February 19, 2013.
Online issue publication
December 04, 2013
Article Versions
- Previous version (19 February 2013).
- Previous version (26 February 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions